Caring Brands, Inc. (CABR) — Current Report

AI-Powered SEC Filing Analysis

← All CABR filings

Want the newest filings?

This analysis covers the filing from 2026-04-10. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-03-31
  • Caring Brands, Inc. (CABR) has reduced the quorum requirement for shareholder meetings from a majority to 33 1/3%, which could make it easier for the company to hold such meetings.
  • The company has appointed its Chief Investment Officer and Chairman of the Board, Brian John, as the Interim Chief Financial Officer, citing his proven track record in driving business growth and experience in managing publicly traded companies.
  • The appointment of an Interim CFO could indicate potential financial or leadership changes within the company, which investors should monitor going forward.
Filed: 2026-03-24
  • Caring Brands raised $3.6 million in a PIPE offering, issuing 3.8 million shares of Series A Convertible Preferred Stock and 9.5 million warrants. The proceeds will be used to retire 6.25 million shares of common stock held by insiders.
  • The PIPE offering provides Caring Brands with additional capital to fund operations and strategic initiatives, while reducing the total outstanding shares of common stock through the insider share redemptions.
  • Caring Brands granted the PIPE investor the right to purchase up to an additional $4 million of Series A Preferred Stock and Warrants, providing potential for further capital raises on favorable terms for the company.
Filed: 2026-02-03
  • Caring Brands, Inc. has been granted two new U.S. patents related to its proprietary Hair Enzyme Booster product, strengthening the company's intellectual property portfolio.
  • The company is an emerging growth company, indicating it is in an early stage of development and may be subject to higher risk but also higher growth potential.
  • The company's principal executive offices are located in Fort Pierce, Florida, which could impact its operational and financial performance depending on local economic conditions.
Filed: 2026-01-09
  • The Chief Financial Officer, Tyler Moore, has resigned from Caring Brands, Inc. This leadership change could signal potential changes in the company's financial strategy or management.
  • Caring Brands, Inc. has commenced a search for a new Chief Financial Officer, indicating the company is actively working to fill this key role in the near term.
  • The company stated that Mr. Moore's resignation was not due to any disagreement on the company's operations, policies, or practices, suggesting an amicable departure.
Filed: 2026-01-05
  • Caring Brands has entered into an exclusive, worldwide license agreement with Itonis Pharmaceuticals to manufacture, market and sell Itonis's homeopathic Emesyl product, which could provide a new revenue stream for the company.
  • The license agreement includes a royalty of 8% of net sales for Caring Brands, as well as the potential for Caring Brands to receive 7% of Itonis's equity for every $200,000 in product sales, incentivizing the successful commercialization of the product.
  • The license agreement includes provisions for termination if product sales fall below $25,000 for four consecutive quarters, which poses a risk if the Emesyl product fails to gain traction in the market.

Other reports for Caring Brands, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.